Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-effectiveness of ocular interventions.

Brandon G Busbee1, Gary C Brown, Melissa M Brown

  • 1The Center for Evidence-Based Health Care Economics, Retina Vascular Unit, Cataract and Primary Eye Care Service, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania, USA. bgbusbee@yahoo.com

Current Opinion in Ophthalmology
|June 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study.

EClinicalMedicine·2023
Same author

Cost-Utility Analysis of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.

Ophthalmology. Retina·2023
Same author

Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost-Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration.

Ophthalmology and therapy·2023
Same author

Preference-based comparison of quality of life associated with vision loss in Black and White ophthalmic populations in the US.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2022
Same author

Quality of life associated with no light perception vision.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2022
Same author

Re: Le et al.: Associations between age-related eye diseases and Charles Bonnet Syndrome in participants of the Age-Related Eye Disease Study 2: Report Number 26 (Ophthalmology. 2022;129:233-235).

Ophthalmology·2022

This study explores cost-effectiveness analysis in ophthalmology, using patient utility values to assess intervention value. It provides a framework for evaluating ophthalmic procedures and comparing their value across medical fields.

Area of Science:

  • Ophthalmology
  • Health Economics
  • Decision Analysis

Background:

  • Rising US healthcare budgets necessitate cost-effectiveness evaluations.
  • Utility analysis offers an objective method for assessing intervention value in disease management.
  • Ophthalmology has a growing body of literature utilizing patient preference-based outcomes.

Purpose of the Study:

  • To outline the methodology of cost-utility analysis in ophthalmology.
  • To provide a reference case for initial cataract surgery cost-effectiveness.
  • To compare the value of ophthalmic interventions with those in other medical specialties.

Main Methods:

  • Utility analysis based on patient preferences.
  • Cost-utility analysis integrating costs and utility values.

Related Experiment Videos

  • Comparative study design for inter-specialty value assessment.

    • Main Results:

    • Cost-utility analysis provides a framework for valuing ophthalmic procedures.
    • Cataract surgery serves as a reference case for economic evaluation.
    • Value of ophthalmic interventions can be compared across different medical fields.

    Conclusions:

    • Cost-effectiveness analysis is crucial for resource allocation in ophthalmology.
    • Patient-centered outcomes are key to robust utility analysis.
    • This methodology enables informed decision-making for ophthalmic interventions.